(Reuters) – Moderna Inc said on Tuesday it was moving forward the supply targets for the second 100 million of its COVID-19 vaccine doses to the United States by a month to May end.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shounak Dasgupta)
